Document Type : Research Article
Authors
1 Department of Nuclear Engineering and Physics, Amirkabir University of Technology, Tehran, Iran
2 Nuclear Science Research School, Nuclear Science and Technology Research Institute NSTRI, Tehran, Iran
Abstract
Utilizing radioactive stents is a usual method for treatment of advanced esophageal cancer. It is necessary to investigate the dose distribution of radioactive esophageal stents before the clinical use. This study presents a dosimetric comparison between three radioactive esophageal stents: I-125 seed-loaded stent, iodine-eluting stent and double-layered iodine-eluting stent. Depth-dose and angular dose distributions were carried out using Geant4 toolkit. Moreover, the effect of interval distance between two adjacent seeds on the dose distribution was investigated. Esophageal stents loaded with I-125 seeds seems to be better than iodine-eluting stents, with the distance less than 15 mm between two adjacent seeds.
Highlights
- Esophageal stents carrying I-125 seeds have shown advantages over iodine-eluting stents.
- The dose distribution of esophageal seed-loaded stents, signi cantly depends on the arrangements of the seeds.
- Appropriate dose distribution was achieved for esophageal stents carrying I-125 seeds with 15 mm inter-seed spacing.
Keywords
Agostinelli, S., Allison, J., Amako, K. A., et al. (2003). GEANT4–a simulation toolkit. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 506(3):250-303.
Chiu-Tsao, S.-T., Schaart, D. R., Soares, C. G., et al. (2007). Dose calculation formalisms and consensus dosimetry parameters for intravascular brachytherapy dosimetry: Recommendations of the AAPM Therapy Physics Committee Task Group No. 149. Medical Physics, 34(11):4126–4157.
Chu, J., Jin, J., Ni, S., et al. (2008). Radiation field feature of 188Re esophageal stent. Nuclear Medicine Communications, 29(5):462–464.
Dai, Z., Zhou, D., Hu, J., et al. (2013). Clinical application of iodine-eluting stent in patients with advanced esophageal
cancer. Oncology Letters, 6(3):713–718.
Gaspar, L. E., Nag, S., Herskovic, A., et al. (1997). American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. International Journal of Radiation Oncology Biology Physics, 38(1):127–132.
Geant4 (2017). Geant4 physics reference manual (online available). http://geant4.web. cern.ch/geant4/UserDocumentation/UsersGuides/PhysicsReferenceManual/fo/PhysicsReferenceManual.pdf.
Guo, J.-H., Teng, G.-J., Zhu, G.-Y., et al. (2008). Selfexpandable esophageal stent loaded with 125I seeds: initial experience in patients with advanced esophageal cancer. Radiology, 247(2):574–581.
Kim, E. S., Jeon, S. W., Park, S. Y., et al. (2009). Comparison of double-layered and covered Niti-S stents for palliation
of malignant dysphagia. Journal of Gastroenterology and Hepatology, 24(1):114–119.
Lin, L., Wang, J., Yang, R., et al. (2015). An Experimental Modal Investigation of the Dosimetry Parameters for Self-Expandable Esophageal Stent Loaded With I-125 Seeds. Brachytherapy, 14:S66–S67.
Liu, N., Liu, S., Xiang, C., et al. (2014). Radioactive selfexpanding stents give superior palliation in patients with unresectable cancer of the esophagus but should be used with caution if they have had prior radiotherapy. The Annals of Thoracic Surgery, 98(2):521–526.
Lohrabian, V., Sheibani, S., Aghamiri, M. R., et al. (2013). Determination of dosimetric characteristics of irseed 125I brachytherapy source. Iranian Journal of Medical Physics, 10(2):109–117.
Mariette, C., Piessen, G., and Triboulet, J.-P. (2007). Therapeutic strategies in esophageal carcinoma: role of surgery and other modalities. The Lancet Oncology, 8(6):545–553.
Napier, K. J., Scheerer, M., and Misra, S. (2014). Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. World Journal of Gastrointestinal Oncology, 6(5):112.
Nath, R., Amols, H., Coffey, C., et al. (1999). Intravascular brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 60. Medical Physics, 26(2):119–152.
Rivard, M. J., Coursey, B. M., DeWerd, L. A., et al. (2004). Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Medical Physics, 31(3):633–674.
Won, J. H., Lee, J. D., Wang, H. J., et al. (2002). Selfexpandable covered metallic esophageal stent impregnated with beta-emitting radionuclide: an experimental study in canine esophagus. International Journal of Radiation Oncology Biology Physics, 53(4):1005–1013.
Won, J. H., Lee, J. D., Wang, H. J., et al. (2005). Effects of a holmium-166 incorporated covered stent placement in normal canine common bile ducts. Journal of Vascular and Interventional Radiology, 16(5):705–711.
Yao, L.-H., Wang, J.-J., Shang, C., et al. (2017). In vitro Dosimetric Study of Biliary Stent Loaded with Radioactive 125I Seeds. Chinese Medical Journal, 130(9):1093.
Zhen, C., Ya-hong, C., andWei, L. (2014). Preparation of 125I Radioactive Covered Metal Stent. Tongweisu, 27(2):109–115.
Zhongmin, W., Xunbo, H., Jun, C., et al. (2012). Intraluminal radioactive stent compared with covered stent alone for the treatment of malignant esophageal stricture. Cardiovascular and Interventional Radiology, 35(2):351–358.
Zhu, H.-D., Guo, J.-H., Mao, A.-W., et al. (2014). Conventional stents versus stents loaded with iodine-125 seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial. The Lancet Oncology, 15(6):612–619.
)